Video Player is loading.
Current Time 0:00
/
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time -0:00
1x
- 0.5x
- 0.75x
- 1x, selected
- 1.25x
- 1.5x
- 1.75x
- 2x
- Chapters
- descriptions off, selected
- captions settings, opens captions settings dialog
- captions off, selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
10 seconds
Playback speed
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
2020 SOHO Update on Immunotherapy in AML: Gemtuzumab Ozogamicin Plus 7+3 vs. 7+3, CD123-Targeting ADC IMGN632 & Azacitidine + Nivolumab in R/R AML, Anti-CD47 Antibody Magrolimab + Azacitidine
By
2nd SOHO Italian Conference
FEATURING
Naval Daver
By
2nd SOHO Italian Conference
FEATURING
Naval Daver
122 views
December 7, 2020
Comments 0
Login to view comments.
Click here to Login